Normally blood glucose levels are controlled by the hormone insulin, released by the pancreas when needed but individuals who have diabetes either do not produce insulin, do not generate enough insulin or the insulin they do produce can not work properly. Related StoriesNew scientific trial uses aggressive procedure for individuals with pancreas cancerEndocrine Society to web host Congressional briefing on November 4 to fight diabetes epidemicTumor cells associated with pancreatic cancer use each other to increase tumor spreadThis new gadget is constructed of a metal casing containing a supply of insulin kept in place by a gel barrier. When your body’s sugar levels rise, the gel barrier starts to liquefy and lets insulin out. This insulin goes into the veins around the gut then into the liver acting very much like a normal pancreas would.Food and Medication Administration accepted Farxiga, a once-daily oral medication indicated as an adjunct to exercise and diet to boost glycemic control in adults with type 2 diabetes mellitus. Farxiga is usually marketed as Forxiga outside the United States. Xigduo combines dapagliflozin , a reversible and selective inhibitor of SGLT2 with metformin hydrochloride, two anti-hyperglycemic products with complementary mechanisms of action to boost glycemic control, in a twice daily tablet. In December Eliquis, the company and its partner, Pfizer, announced that the FDA has accepted for review a Supplemental New Medication Program for Eliquis for the treating deep vein thrombosis and pulmonary embolism and for the decrease in the chance of recurrent DVT and PE.